Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy

Transplantation

Volumn 93, Issue 4, 2012, Pages 412-417

  Tent, Hilde ^a   Sanders, Jan Stephan F ^a   Rook, Mieneke ^a   Hofker, H Sijbrand ^a   Ploeg, Rutger J ^a,b   Navis, Gerjan ^a   Van Der Heide, Jaap J Homan ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Donor outcome; Glomerular filtration rate; Hypertension; Living kidney donors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IODOHIPPURATE SODIUM I 131; IOTALAMIC ACID I 125;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BODY MASS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY PLASMA FLOW; LIVING DONOR; MALE; MEAN ARTERIAL PRESSURE; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL RISK; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

BLOOD PRESSURE; CASE-CONTROL STUDIES; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; LIVING DONORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84857036631     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318240e9b9     Document Type: Article

References (23)

1. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 2007; 7: 2333.
2. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
3. Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol 2001; 166: 2043.
4. Gossmann J, Wilhelm A, Kachel HG, et al. Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant 2005; 5: 2417.
5. Sahay M, Narayen G, Anuradha. Risk of live kidney donation-Indian perspective. J Assoc Physicians India 2007; 55: 267.
6. Textor SC, Taler SJ, Driscoll N, et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004; 78: 276.
7. Mjoen G, Midtvedt K, Holme I, et al. One-and five-year follow-ups on blood pressure and renal function in kidney donors. Transpl Int 2011; 24: 73.
8. Prasad GV, Lipszyc D, Huang M, et al. A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation 2008; 86: 1315.
9. Ramesh Prasad GV, Lipszyc D, Sarker S, et al. Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donation. Transpl Int 2010; 23: 771.
10. Talseth T, Fauchald P, Skrede S, et al. Long-term blood pressure and renal function in kidney donors. Kidney Int 1986; 29: 1072.
11. el Agroudy AE, Sabry AA, Wafa EW, et al. Long-term follow-up of living kidney donors: A longitudinal study. BJU Int 2007; 100: 1351.
12. Fehrman-Ekholm I, Duner F, Brink B, et al. No evidence of accelerated loss of kidney function in living kidney donors: Results from a crosssectional follow-up. Transplantation 2001; 72: 444.
13. Eberhard OK, Kliem V, Offner G, et al. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin Transplant 1997; 11: 415.
14. Najarian JS, Chavers BM, McHugh LE, et al. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340: 807.
15. Santos L, Macario F, Alves R, et al. Risks of living donor nephrectomy. Transplant Proc 2010; 42: 1484.
16. Lee JH, Kim SC, Han DJ, et al. Risk factors for MDRD-GFR of less than 60 mL/min per 1.73m2 in former kidney donors. Nephrology (Carlton) 2007; 12: 600.
17. Ommen ES, Schroppel B, Kim JY, et al. Routine use of ambulatory blood pressure monitoring in potential living kidney donors. Clin J Am Soc Nephrol 2007; 2: 1030.
18. Ozdemir FN, Guz G, Sezer S, et al. Ambulatory blood pressure monitoring in potential renal transplant donors. Nephrol Dial Transplant 2000; 15: 1038.
19. Textor SC, Taler SJ, Larson TS, et al. Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol 2003; 14: 2159.
20. Apperloo AJ, de ZD, Donker AJ, et al. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 1996; 7: 567.
21. Visser FW, Muntinga JH, Dierckx RA, et al. Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol 2008; 3: 1308.
22. Donker AJ, van der Hem GK, Sluiter WJ, et al. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 1977; 20: 97.
23. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.